NFE2L2 and colorectal carcinoma: We observed similar results in the colony formation assay. Compared to oxaliplatin or lobaplatin alone, the knockdown of Nrf2 combined with oxaliplatin or lobaplatin formed fewer colonies in CRC cells (Fig. 4D–F).